BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Urgent Field Safety Notice for BOND Ready-to-Use Primary Antibody Bcl-6 (LN22) by Leica Biosystems Newcastle Ltd

Product group In-vitro diagnostics - immunological products
Reference 01567/23

For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.

Urgent Field Safety Notice for BOND Ready-to-Use Primary Antibody Bcl-6 (LN22) by Leica Biosystems Newcastle Ltd , Download_VeroeffentlichtAm_EN PDF, 1MB, File does not meet accessibility standards